Literature DB >> 18516702

The impact of inherited thrombophilia on surgery: a factor to consider before transplantation?

Elias Kfoury1, Ali Taher, Said Saghieh, Zaher K Otrock, Rami Mahfouz.   

Abstract

This article mainly reviews hypercoagulability--and specifically inherited thrombophilia--in different types of surgery including kidney transplantation, simultaneous kidney and pancreas transplantation, orthopedic surgery, vascular surgery, cardiac surgery and other categories of surgical procedures, with a major focus on its associated complications and the need to screen or not. A search was conducted using Medline and cross-referencing for articles related to thrombophilia, screening for it, and its association with surgical complications post-op. Thrombosis associated predisposing entities like factor V Leiden, Prothrombin and Methylene tetrahydrofolate reductase gene mutations, in addition to Protein C and S deficiencies, are discussed. In addition, common and relatively uncommon complications of thrombophilia in the above mentioned surgeries will be covered in length, as well as the necessity to screen for thrombophilia prior to the surgical step. This topic is gaining more and more importance for both surgeons and internists (especially Hematologists) and we, herein, present a general review of the published literature as an update on the subject.

Entities:  

Mesh:

Year:  2008        PMID: 18516702     DOI: 10.1007/s11033-008-9278-4

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  109 in total

1.  Genetic predisposition to thrombosis in renal transplant recipients: the factor V Q506 (Leiden) allele.

Authors:  F R Green
Journal:  Transplantation       Date:  2000-04-27       Impact factor: 4.939

2.  Risk of venous thromboembolism associated with a G to A transition at position 20210 in the 3'-untranslated region of the prothrombin gene.

Authors:  K Brown; R Luddington; D Williamson; P Baker; T Baglin
Journal:  Br J Haematol       Date:  1997-09       Impact factor: 6.998

Review 3.  Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance.

Authors:  P E Love; S A Santoro
Journal:  Ann Intern Med       Date:  1990-05-01       Impact factor: 25.391

4.  Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V.

Authors:  J Voorberg; J Roelse; R Koopman; H Büller; F Berends; J W ten Cate; K Mertens; J A van Mourik
Journal:  Lancet       Date:  1994-06-18       Impact factor: 79.321

5.  APC-resistance is a risk factor for postoperative thromboembolism in elective replacement of the hip or knee--a prospective study.

Authors:  T L Lindahl; T H Lundahl; L Nilsson; C A Andersson
Journal:  Thromb Haemost       Date:  1999-01       Impact factor: 5.249

6.  Coagulation factor V (Arg506-->Gln) mutation and early saphenous vein graft occlusion after coronary artery bypass grafting.

Authors:  E Moor; A Silveira; F van't Hooft; P Tornvall; M Blombäck; B Wiman; L Rydén; A Hamsten
Journal:  Thromb Haemost       Date:  1998-08       Impact factor: 5.249

7.  A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery.

Authors:  A G Turpie; M N Levine; J Hirsh; C J Carter; R M Jay; P J Powers; M Andrew; R D Hull; M Gent
Journal:  N Engl J Med       Date:  1986-10-09       Impact factor: 91.245

8.  Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery.

Authors:  Yackov Berkun; Amir Elami; Karen Meir; Dror Mevorach; Yaakov Naparstek
Journal:  J Thorac Cardiovasc Surg       Date:  2004-02       Impact factor: 5.209

9.  A single center's experience with 308 free flaps for repair of head and neck cancer defects.

Authors:  M A Schusterman; M J Miller; G P Reece; S S Kroll; M Marchi; H Goepfert
Journal:  Plast Reconstr Surg       Date:  1994-03       Impact factor: 4.730

10.  Hypercoagulable states and lower limb ischemia in young adults.

Authors:  J Eldrup-Jorgensen; D P Flanigan; L Brace; A P Sawchuk; S G Mulder; C P Anderson; J J Schuler; J R Meyer; J R Durham; T H Schwarcz
Journal:  J Vasc Surg       Date:  1989-02       Impact factor: 4.268

View more
  2 in total

1.  The frequency of factor V Leiden mutation, ACE gene polymorphism, serum ACE activity and response to ACE inhibitor and angiotensin II receptor antagonist drugs in Iranians type II diabetic patients with microalbuminuria.

Authors:  Zohreh Rahimi; Vahid Felehgari; Mehrali Rahimi; Hadi Mozafari; Kheirollah Yari; Asad Vaisi-Raygani; Mansour Rezaei; Shohreh Malek-Khosravi; Habibolah Khazaie
Journal:  Mol Biol Rep       Date:  2010-09-19       Impact factor: 2.316

2.  Multidisciplinary Practice Variations of Anti-Thrombotic Strategies for Free Tissue Transfers.

Authors:  Minh N Q Huynh; Vinai Bhagirath; Michael Gupta; Ronen Avram; Kevin Cheung
Journal:  Plast Surg (Oakv)       Date:  2021-06-23       Impact factor: 0.558

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.